Evidence map›Paper›PMID 31248154›Full record

ReviewInternational journal of molecular sciences2019

The Role of Telomerase and Telomeres in Interstitial Lung Diseases: From Molecules to Clinical Implications.

Nissim Arish, Dmytro Petukhov, Shulamit B Wallach-Dayan

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Role of Telomeres and Telomerase in Cancer and Aging.International journal of molecular sciences · 2023
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Cellular Senescence: Pathogenic Mechanisms in Lung Fibrosis.International journal of molecular sciences · 2021
    Review
  17. Regenerative Medicine and the Hope for a Cure.Clinics in chest medicine · 2021
    Review
  18. Review
  19. Review
  20. Revesz syndrome revisited.Orphanet journal of rare diseases · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nissim ArishPulmonary Institute, Shaare Zedek Medical Center, P.O. Box 3235, 12 Shmuel Bait St., 9103102 Jerusalem, Israel. nissim.arish@gmail.com.
Dmytro PetukhovLung Cellular and Molecular Biology Laboratory, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, P.O. Box 12000, Qiryat Hadassah, 91120 Jerusalem, Israel. petukhov@hadassah.org.il.
Shulamit B Wallach-DayanLung Cellular and Molecular Biology Laboratory, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, P.O. Box 12000, Qiryat Hadassah, 91120 Jerusalem, Israel. wallach-dayan@hadassah.org.il.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Telomeres are distal chromosome regions associated with specific protein complexes that protect the chromosome against degradation and aberrations. Telomere maintenance capacity is an essential indication of healthy cell populations, and telomere damage is observed in processes such as malignant transformation, apoptosis, or cell senescence. At a cellular level, telomere damage may result from genotoxic stress, decreased activity of telomerase enzyme complex, dysfunction of shelterin proteins, or changes in expression of telomere-associated RNA such as TERRA. Clinical evidence suggests that mutation of telomerase genes (

Indexed as

AnimalsCell Transformation, NeoplasticDisease SusceptibilityGene Expression RegulationGenetic Association StudiesHumansLung Diseases, InterstitialMutationRNA, Long NoncodingTelomeraseTelomereRNA, Long NoncodingTelomeraseTERT protein, humanidiopathic pulmonary fibrosisinterstitial lung diseaselong noncoding RNAshelterintelomerasetelomere

Identifiers

PMID31248154
PMCPMC6627617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.